Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
New England Journal of Medicine · 10.08.2023 · 389 (6) · 491-503
DOI: 10.1056/nejmoa2302983 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 10.08.2023. Verfasst von Heather Wakelee und 19 weiteren Autor:innen. Beteiligte Einrichtung: From Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA (H.W.); Centre Hospitalier de l'Université de Montréal (M.L.) an…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 1183-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Merck Sharp and Dohme LLC, a subsidiary of Merck & Co, Inc, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA (H.W.); Centre Hospitalier de l'Université de Montréal (M.L.) and McGill University Health Centre (J.D.S.) - both in Montreal; Kanagaw…
Förderung
- NCI NIH HHS
- Merck Sharp and Dohme LLC, a subsidiary of Merck & Co, Inc
- National Cancer Institute
Zitieren
APA
Wakelee, H., Liberman, M., Kato, T., Tsuboi, M., Lee, S. H., Gao, S., Chen, K. N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G. L., Bylicki, O., Rodríguez-Abreu, D., Chaft, J. E., Novello, S., Yang, J., Keller, S. M., Samkari, A., Spicer, J. D., & KEYNOTE-671 Investigators (2023). Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer. New England Journal of Medicine, 389(6), 491-503. https://doi.org/10.1056/nejmoa2302983
Vancouver
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer. New England Journal of Medicine. 2023;389(6):491-503. doi:10.1056/nejmoa2302983
BibTeX
@article{Wakelee2023,
author = {Wakelee, Heather and Liberman, Moishe and Kato, Terufumi and Tsuboi, Masahiro and Lee, Se-Hoon and Gao, Shugeng and Chen, Ke-Neng and Dooms, Christophe and Majem, Margarita and Eigendorff, Ekkehard and Martinengo, Gastón L and Bylicki, Olivier and Rodríguez-Abreu, Delvys and Chaft, Jamie E and Novello, Silvia and Yang, Jing and Keller, Steven M and Samkari, Ayman and Spicer, Jonathan D and KEYNOTE-671 Investigators, KEYNOTE-671 Investigators},
title = {Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {6},
pages = {491--503},
doi = {10.1056/nejmoa2302983}
}
EUVIMED